Diagnos Laboratorium Utama Tbk. vs Samudera Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Samudera Indonesia Tbk. trades at Rp286 (market cap 4.62T, 3.34M 24h volume). The key difference: Samudera Indonesia Tbk. is far larger — about 15× Diagnos Laboratorium Utama Tbk.'s market cap, and Samudera Indonesia Tbk. is more actively traded (3.34M versus 129.6K). Which is the better fit depends on your goals.
| DGNS | SMDR | |
|---|---|---|
Market Cap | 308B | 4.62T |
Volume | 129.6K | 3.34M |
Lot | 1.3K | 33.4K |
Turnover | 28.71M | 955.52M |
Average Price | 221.54 | 286.12 |
Value | 28.71M | 955.52M |
Indicative Equilibrium Price | 230 | 286 |
Indicative Equilibrium Volume | 110 | 1.47K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Samudera Indonesia Tbk (the Company) was established on November 13, 1964 under the framework of the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on notarial deed No. 33 of Soeleman Ardjasasmita, S.H. PT. Samudera Indonesia Tbk offers a full range of transportation services from feeder, tanker, offshore and land transportation for containers and heavy equipment to container depots and warehousing as well as freight forwarding services. In 1997, SSL, a subsidiary, listed on the Singapore Exchange Securities Trading Ltd.
Read more on SMDR →